Description
Mod GRF 1-29(CJC-1295 No Dac) + Hexarelin Injection Research Overview
Disclaimer: The compounds described on this page are intended for laboratory research use only and are not approved for human consumption.
Overview of Mod GRF 1-29(CJC-1295 No Dac) + Hexarelin
Mod GRF 1-29 (CJC-1295 No DAC) and Hexarelin are studied together in research models to know their combined effects on growth hormone release dynamics. This blend produces a strong growth hormone response in research models. It increases anabolic signaling, metabolic activity, and improves recovery markers in test models.
The table below shows the composition of each compound in Mod GRF 1-29(CJC-1295 No Dac) + Hexarelin Injection.
Compound |
Amount (mg) |
Percentage of Total |
| Mod GRF 1-29 (CJC-1295 No DAC) | 5mg | 50% |
| Hexarelin | 5mg | 50% |
| Total | 10mg | 100% |
Mod GRF 1-29(CJC-1295 No Dac)
Mod GRF 1-29, also referred to as CJC-1295 without DAC, is a synthetic peptide. It is derived from growth hormone-releasing hormone (GHRH). It is based on the first 29 amino acids of the natural GHRH sequence, which represent the active region studied in research.
This peptide version is studied for its role in affecting growth hormone signaling pathways in research models. Its defined structure and predictable behavior can be beneficial in growth hormone–related research.
| Section | Details |
|---|---|
| CAS Number | 863288-34-0 |
| Molar Mass | 3367.9 g/mol [R] |
| Chemical Formula | C152H252N44O42 |
| IUPAC Name | H-DL-Tyr-DL-Ala-DL-Asp-DL-Ala-DL-xiIle-DL-Phe-DL-xiThr-DL-Gln-DL-Ser-DL-Tyr-DL-Arg-DL-Lys-DL-Val-DL-Leu-DL-Ala-DL-Gln-DL-Leu-DL-Ser-DL-Ala-DL-Arg-DL-Lys-DL-Leu-DL-Leu-DL-Gln-DL-Asp-DL-xiIle-DL-Leu-DL-Ser-DL-Arg-NH2 |
| Synonyms | CJC1295 Without DAC, Mod GRF 1-29, CJC-1295 no DAC, CJC-1295 with no DAC |
| Shelf Life | 24 to 36 months |
| Compound’s Disclaimer | Mod GRF 1-29 is not approved for human use. It is available for research purposes only. |
Hexarelin
Hexarelin is a synthetic hexapeptide that belongs to the growth hormone–releasing peptide (GHRP) class. It is studied for its strong ability to promote endogenous growth hormone release in research models. Hexarelin is a potent compound that is observed for affecting growth hormone dynamics in research models.
The increased growth hormone levels due to Hexarelin affect biological processes like anabolic signaling, metabolic efficiency, and energy utilization in research. Studies also report effects on muscle structure and fat metabolism in research models.
| Section | Details |
|---|---|
| CAS Number | 140703-51-1 [R] |
| Molar Mass | 887.0 g/mol |
| Chemical Formula | C47H58N12O6 |
| IUPAC Name | (2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(2-methyl-1H-indol-3-yl)propanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide |
| Synonyms | Examorelin, EP-23905, examorelina, examoreline, MF-6003, examorelinum |
| Shelf Life | 24 months |
| Compound’s Disclaimer | Hexarelin is not approved for human use. It is available for research purposes only. |
Mod GRF 1-29(CJC-1295 No Dac) + Hexarelin’s Mechanism of Action
Mod GRF 1‑29 stimulates the pituitary through the GHRH pathway in research models. Hexarelin, on the other hand, activates the ghrelin receptor in test models. These compounds work on separate pathways that amplify and sustain growth hormone release to produce a stronger GH pulse than either of these peptides alone.
Why Consider Mod GRF 1-29(CJC-1295 No Dac) + Hexarelin Injection for Research?
Researchers may consider Mod GRF 1-29(CJC-1295 No Dac) + Hexarelin Injection based on its intended research application, available specifications, and supporting documentation.
- Mod GRF 1-29(CJC-1295 No Dac) + Hexarelin blend’s purity is confirmed at 99.8%.
- Mod GRF 1-29 assay results at 98.9% and Hexarelin at 99.2%. They are within the USP specification range of 97.0%–103.0%.
- The endotoxin levels of this injection measure below 0.5 EU/mL. It remains below the 5 EU/mL limit.
- The heavy metals are detected at less than 5 ppm. This meets the safety thresholds for research use.
- This blend comes with a detailed Certificate of Analysis for research validation.
For queries, complaints, or support, please contact help@ironmountainlabz.com
Frequently Asked Questions
Is Mod GRF 1-29 + Hexarelin Injection legal in the United States?
Mod GRF 1-29 + Hexarelin Injection is not approved by the FDA for human use. So, this blend is available for research purposes only.
What does Mod GRF 1-29 + Hexarelin Injection do in research models?
Mod GRF 1-29 + Hexarelin is studied for its effect on GH release in research models. Mod GRF 1-29 acts by signaling the pituitary to trigger GH secretion. Hexarelin, on the other hand, stimulates GH release through a different receptor pathway in test models. Researchers study its effects on metabolic activity and anabolic-related pathways in research models.
Is Mod GRF 1-29 + Hexarelin Injection safe in research?
Mod GRF 1-29 + Hexarelin Injection’s safety depends on factors such as dose and study duration. Some research models also show temporary hormone-related changes in research. However, the long-term data on this blend is limited, and it is intended for research purposes only.
What are the storage instructions for this injection?
This injection should be stored in a refrigerator at 2–8°C. Keep this vial away from light and always store it in a sealed container.
Where can readers find vendor information for Mod GRF 1-29(CJC-1295 No Dac) + Hexarelin Injection?
Iron Mountain Labz provides research information and affiliate purchasing pathways but does not directly sell, manufacture, warehouse, or ship Mod GRF 1-29(CJC-1295 No Dac) + Hexarelin Injection. Readers should assess third-party suppliers independently and review available identity, purity, and batch-testing documentation.
IML Affiliate Disclosure
Some links on IML may connect readers with third-party suppliers through affiliate arrangements. IML may receive compensation from qualifying transactions at no additional cost to the reader, but the third-party supplier remains responsible for the actual sale, fulfillment, and product documentation.
